Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Tag Archives: TRIPS
IP negotiations at the UN High-Level Meeting on HIV/AIDS
UN High Level Meeting on HIV/AIDS is set to take place from 8–10 June 2011 in New York to review progress and chart the future course of the global AIDS response. Member States are expected to adopt a new Declaration … Continue reading
Posted in HIV/Aids, TRIPS, TRIPS plus, UN General Assembly HLM
Tagged EU, FTAs, GFATM funding, HIV treatment targets, HIV/Aids, Intellectual property, TRIPS, TRIPS flexibilities, UNGASS
3 Comments
Press: EU’s pharma trade hoax
Source: The Hindu Business Line, 25.2.2011, by Tahir Amin/Priti Radhakrishnan The proposed India-EU trade pact is riddled with intellectual property provisions that would harm India’s 2005 Patent Act. Last month, the global health community cheered when India’s patent office ruled … Continue reading
Posted in EU-India FTA
Tagged EU, FTA, Generic drug, HIV/Aids, India, Intellectual property, TRIPS
Leave a comment
Blog: India and Europe Trading Away Access to Medicines
Source: Open Society Foundation Blog Recent news reports <http://www.indianexpress.com/news/dont-swallow-this-pill/742546/0> on negotiations between India and the European Union on a proposed free trade agreement (FTA) have many health and human rights experts worried that millions of people may be left without … Continue reading
Press: IPA concerned over PMO’s efforts to destabilize India’s IPR regime at the behest of EU
Source: Pharmabiz, 27.1.2011, by Ramesh Shankar The Indian Pharmaceutical Alliance (IPA), an association of leading Indian pharma companies, has raised alarm over the recent media reports that efforts are going on in the Prime Ministers Office (PMO) to destabilize India’s … Continue reading
Posted in EU-India FTA
Tagged EU, FTA, Generic drug, India, TRIPS, World Trade Organization
Leave a comment
DNP+ letter to WHO on impact study on IP provisions in the India-EU FTA
WHO’s impact study on IP provisions in the India-EU FTA Dear Dr. Plianbangchang, I am writing on behalf of the Delhi Network of Positive People (DNP+). Our organization was founded in 1999 as a support group of people living with … Continue reading
Posted in EU-India FTA, Letters to officials
Tagged DNP+, EU, FTA, Generic drug, HIV/Aids, India, Intellectual property, TRIPS
Leave a comment
Press: EU still pushing data exclusivity through FTA, India stands firm
Source: Pharmabiz, 22.1.2011, by Joseph Alexander European Union is still pushing India to accept TRIPS-plus data exclusivity provisions through the proposed Free Trade Agreement though India is still firmly against it, if the latest draft chapter on intellectual property rights … Continue reading
Documents: Oxfam study on data exclusivity in the US-Jordan FTA
Oxfam briefing paper – All costs, no benefits: How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines “The USA continues to impose TRIPS-plus rules on developing countries, thus preventing poor people from accessing inexpensive, generic medicines. … Continue reading
IP Watch: Europe’s Outlook For 2011: EU Patent, Digital Content, Innovation And Free Trade
Source: Intellectual Property Watch, 13.01.2011, by Dugie Standeford Excerpt – “New Medical Innovation Models Coming? In November 2010, the European Parliament hosted a discussion on biomedical innovation with a view to formulating EU policies, Knowledge Ecology International, TransAtlantic Consumer Dialogue, … Continue reading
Data Exclusivity and India-EU FTA: Interview with D.G. Shah of Indian Pharmaceutical Alliance
Interview with D.G. Shah, Secretary-General of Indian Pharmaceutical Alliance (IPA) New Delhi, 13.01.2011 – This week another round of negotiations between the EU and India on a bilateral free trade and investment agreement (India-EU FTA) is taking place in New … Continue reading
Press: Indian Lobby Warns Of Proposed EU-India Free Trade Agreement’s Impact; Says Drug Supplies Of Developing Nations May Be In Jeopardy
Source: Pharmasianews, 07.01.2011 MUMBAI – As India and the European Union draw closer to signing a comprehensive Free Trade Agreement, the Indian Pharmaceutical Alliance – an influential lobby group of leading Indian pharmaceutical companies – has appealed to the Indian … Continue reading
